Urinary bladder pyogenic granuloma: a case report

Mukai, Shoichiro; Tanaka, Hiroyuki; Yamasaki, Kouji; Goto, Takayuki; Onizuka, Chie; Kataoka, Hiroaki

doi:10.1186/1752-1947-6-149

Cited by 16 publications

(28 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Congenital pyogenic granuloma (CPG) is a rare clinical presentation. The majority of these cases affect mucosal surfaces, and there are only nine reported cases describing skin lesions . Here, we report two cases of cutaneous CPG, including one with disseminated disease.…”

Section: Introductionmentioning

confidence: 85%

“…CPG affecting mucosal surfaces has been reported by otolaryngologists as a unique and friable lesion that usually affects the oral cavity, larynx, pharynx and genitourinary mucosa. Unfortunately, in many of the reported cases of CPG affecting mucosa, immunohistochemistry studies for GLUT1 were not performed …”

Section: Discussionmentioning

confidence: 99%

“…Unfortunately, in many of the reported cases of CPG affecting mucosa, immunohistochemistry studies for GLUT1 were not performed. [8][9][10][11] CPG affecting skin is even rarer, and nine case reports are listed in the English literature. 4,6,[11][12][13][14][15] In these nine reported cases, five were tested and resulted negative for GLUT1 by immunohistochemistry.…”

Section: Patientmentioning

confidence: 99%

“…The majority of these cases affect mucosal surfaces, and there are only nine reported cases describing skin lesions. 4,[6][7][8][9][10][11][12][13][14][15] Here, we report two cases of cutaneous CPG, including one with disseminated disease.…”

mentioning

confidence: 99%

See 3 more Smart Citations

Congenital cutaneous pyogenic granuloma: Report of two cases and review of the literature

Schneider

Garcia

Aleixo³

et al. 2019

J Cutan Pathol

View full text Add to dashboard Cite

Congenital cutaneous pyogenic granuloma is a rare benign vascular tumor with clinical and histopathological features similar to infantile hemangioma. It usually presents as a red, pedunculated and highly friable papule. On histopathological analysis, one can see a capillary vessel proliferation with lobular pattern and endothelial proliferation. The differential diagnosis is based on negativity of glucose transporter 1 (GLUT1) immunochemistry studies. We report two infants with congenital pyogenic granuloma, one with a unique cutaneous lesion and the other with multiple lesions affecting both skin and mucosal surfaces. These two cases highlight the importance of the differential diagnosis based on the GLUT1 immunochemistry analysis considering the distinct treatments required to these infant vascular tumors.

show abstract

Section: Introductionmentioning

confidence: 85%

Section: Discussionmentioning

confidence: 99%

Section: Patientmentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Congenital cutaneous pyogenic granuloma: Report of two cases and review of the literature

Schneider

Garcia

Aleixo³

et al. 2019

J Cutan Pathol

View full text Add to dashboard Cite

show abstract

“…Careful histopathological and immunohistochemical studies are required to establish the correct diagnosis. [1][2] . Although hemangioma in the genitourinary system occurs relatively infrequently, bladder hemangioma has arisen during medical research.…”

Section: Introductionmentioning

confidence: 99%

Case Report on Hemangioma of The Urinary Bladder: two rare cases and literature review

Zhao

Mishra

Yang

et al. 2020

Preprint

View full text Add to dashboard Cite

Abstract Background: Although hemangioma in the genitourinary system occurs relatively infrequently, bladder hemangioma has arisen during medical research. We describe two rare cases of urinary bladder hemangioma (UBH), in which was confirmed histopathology followed by Immunohistochemistry (IHC) and review the literature on the diagnosis and treatment of patients with this disease to raise awareness of urinary bladder hemangioma and appropriate management.Case presentation: A 41-year-old Chinese female presented with a sudden onset of painless gross hematuria for one month, Multi-Slice spiral computed tomography urography in the urological system showed the anterior and superior wall thickening of the bladder, multiple nodules and masses, exhibited multiple punctate calcifications and marked uneven enhancement. The second case is a 30-year-old female who was asymptomatic and incidentally founded a large bladder tumor during a routine examination from outside hospital, magnetic resonance imaging scan confirmed a 6.2cm x 6.9cm x 5.2cm soft tissue mass arising from the right anterior and superior wall of the bladder, which suggested the possibility of a benign bladder tumor. Postoperative pathology confirmed the diagnosis of urinary bladder hemangioma. The radical cystectomy was performed with open-methods surgery associated with an abdominal wall ostomy of the ileal outlet tract for case 1. And case 2 finally underwent a Laparoscopic partial cystectomy. Hematuria resolved postoperatively and no evidence of tumor recurrence in three year follow-ups for case 1. Postoperative urinary and pelvic ultrasonography showed no signs of recurrence in three months follow-ups for case 2.Conclusion: Urinary bladder hemangioma is a benign non-urothelial tumor that rarely occurred in pediatric and adolescent patients . Clinical and radiological examinations are not adequate for an accurate diagnosis. Careful histopathological and immunohistochemical studies are required to establish the correct diagnosis. There is no ‘gold standard’ treatment for UBH, treatment options are varied for individuals with favorable follow-ups.

Urinary bladder pyogenic granuloma: a case report

Cited by 16 publications

References 10 publications

Congenital cutaneous pyogenic granuloma: Report of two cases and review of the literature

Congenital cutaneous pyogenic granuloma: Report of two cases and review of the literature

Case Report on Hemangioma of The Urinary Bladder: two rare cases and literature review

First reports of serious adverse drug reactions in recent weeks

Contact Info

Product

Resources

About